Andere Sprachen Haisco Pharmaceutical Group Co., Ltd.

Aktien

002653

CNE100001BC7

002653

Pharmazeutika

Schlusskurs Shenzhen S.E. Andere Börsenplätze 05.12.2025			% 5 Tage	Veränd. 1. Jan.
60.19 ^CNY	-0.38%		+0.62%	+81.02%

04.11.	Haisco Pharma erhält Zulassung für klinische Studie zu Myasthenia-Gravis-Medikament	MT
29.10.	Haisco Pharmaceutical verzeichnet im dritten Quartal einen Gewinnrückgang von 23 % und einen Umsatzanstieg von 22 %	MT

Andere Sprachen

Haisco Pharma Gets Nod for Myasthenia Gravis Drug Trial	04.11.
Haisco Pharmaceutical's Q3 Profit Down 23%, Revenue Up 22%	29.10.
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	28.10.
Haisco Pharmaceutical's Kidney Drug Gains Breakthrough Therapy Designation in China	14.10.
Haisco Pharmaceutical Gets Acceptance for Investigational New Drug Application for Muscular Dystrophy Indication	10.10.
Haisco Pharmaceutical Gets Regulatory Greenlight for Pediatric Use of Anesthetic; Shares Down 3%	23.09.
Haisco Pharmaceutical Gets Regulatory Approval for New Indication of Anruikefen Injection	16.09.
Haisco Pharmaceutical Gets China Clinical Trial Approval for Autoimmune Disease Drug	04.09.
Haisco Pharmaceutical Gets Nod From US FDA to Trial Lymphoma Drug	02.09.
Haisco Pharmaceutical Group H1 Profit Down 22%, Revenue Up 19%	25.08.
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	22.08.
Haisco Pharmaceutical Gets Clinical Trial Approval for Blood Cancer Drug; Shares Jump 6%	13.08.
Haisco Pharmaceutical Gets Nod to Trial Autoimmune Disease Drug	08.08.
Haisco Pharmaceutical Group Gets US FDA Acceptance for New Drug Application for Anesthetic	01.08.
Haisco Pharmaceutical Receives US FDA Approval for Autoimmune Drug Trials	16.07.
Haisco Pharmaceutical to Raise 1.37 Billion Yuan via Share Placement; Shares Slump 5%	07.07.
Haisco Pharmaceutical Gets Clinical Trial Nod for Muscle Dystrophy Drug	02.07.
Haisco Pharmaceutical Group Gets Acceptance Notice for New Indication for HSK47388	25.06.
Chinese Drug Regulator Accepts Haisco Pharmaceutical's Application for Autoimmune Drug's Trial	03.06.
Haisco Pharmaceutical Group Co., Ltd. Approves A Share Cash Dividend for the Year 2024, Payable on 15 May 2025	07.05.
Intech Biopharm Ltd. Signs Supplemental Agreement for the SYN010 Product with Haisco Pharmaceutical Group	06.05.
Declaration of Voting Results by Haisco Pharmaceutical Group	06.05.
Haisco Pharmaceutical Group Co Receives a Proposal from Wang Junmin	24.04.
Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	24.04.
Haisco Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024	14.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Haisco Pharmaceutical Group Co., Ltd.

Aktien

002653

CNE100001BC7

002653

Pharmazeutika

Andere Sprachen

Filter